AIDS Journal

Hoy el #DrCastaño explicando trabajo @AIDS_Journal sobre #toxoplasmosis🎠🧠serie 63 pacientes con 79% supervivencia👏 y mortalidad sobre todo 1er año⚰️.Importancia del DIAGNÓSTICO PRECOZ #VIH ⏳🧪para evitar esta infección y #pronóstico y #manejo en 👉🏻🔗 🆓journals.lww.com/aidsonline/ful…

This case-control study among adolescents with perinatally acquired HIV in Nigeria demonstrated that poor oral health correlates with diminished cognitive performance, supporting integration of oral health screening in HIV care. 🔗👉 ow.ly/xUKf50YFybH @stephshiau

New @HopkinsMedicine study in @AIDS_Journal (journals.lww.com/aidsonline/ful…) predicts #HIV transmission will rise in 30 states & DC if parts of Ryan White HIV/AIDS (@HivRyan) Program end. Program is major source of HIV/AIDS med care, treatment & support in U.S. @Hopkins_GIM @JHMed_ID

This large CDC US study among persons initiating PrEP found that only a minority was tested for HIV before starting PrEP showing the need to strengthen education about the management guidelines to avoid careless use of this important prevention method. 🔗 ow.ly/zBc850Ypvje

A new paper published in @AIDS_Journal shares findings from @usask professor Dr. David Blackburn’s research! Waniska joined the study to assist with Indigenous community engagement to ensure the voices of those with lived/living experience were heard. journals.lww.com/aidsonline/ful…

🌟This significant modelling study shows how these programs are crucial to declines in new infections and highlights the importance of programs tailored to serve populations disproportionately affected by HIV, for lowering overall HIV incidence.🌟

With HIV prevalence of around 25%, Eswatini was among the first countries to achieve the 95-95-95 treatment targets, with dedicated programs for key populations like female sex workers. Read more on the impact of this achievement in this study below👇 🔗ow.ly/QoNc50Y83EH

This US study found that higher use of non-ART medications among PLHIV is associated with poorer cognitive function, highlighting the need for strategies to manage polypharmacy among PLHIV. ow.ly/I4Cp50XGb0R @YanxunXu

During the early stages of the Covid-19 pandemic a substantial reduction in new HIV infections and diagnoses occurred among MSM in Australia, primarily due to a decrease in the number of sexual partners. Read more in this latest study! 🔗👉 ow.ly/He4Z50XzVFl

Check out this latest paper in @AIDS_Journal here! 🔗👉ow.ly/P2ow50XBIjt

During the early stages of the Covid-19 pandemic a substantial reduction in new HIV infections and diagnoses occurred among MSM in Australia primarily due to a decrease in the number of sexual partners. Check out this paper from our latest issue! 🔗👉 ow.ly/2qxV50Xu7Rq

@SESSTIM @agenceANRS

Although transgender women living with HIV in France have a high viral suppression rate, structural barriers such as difficulties obtaining health insurance and gender-concordant identity documents persist and may impede optimal health outcomes. 🔗👉 ow.ly/khuu50Xu7JT

This study in a very large WHO database showed a consistently high in-hospital mortality risk among PLHIV compared with HIV-negative individuals during all SARS-CoV2 variant waves. Visit the link below to read, it's Open Access! 🔗👉ow.ly/GtVu50XlHcX

A new study from Canada shows that older people with HIV infection are at increased risk of frailty and falls related to inappropriately-prescribed medications, particularly the use of sedative and anti-cholinergic drugs. Read here! 👇 🔗 ow.ly/1bw950Xgc5p

Congratulations to @durstenfeld at @DOM_UCLA and the team on this important paper! @CNICSnetwork

Authors show the PREVENT algorithm from the American Heart Association does not adequately predict #cardiovasculardisease risk in a large multicentre cohort of PWH in the USA & may lead to failure to prescribe statins to PWH unless guidelines change. 🔗 ow.ly/U7iG50X8kez

Examining the epidemiology of Kaposi Sarcoma (KS) in the US between 1996 and 2016, authors found that the KS risk was still elevated among PWH in the current treatment era and that consistent HIV control impacts prognosis. 🔗👉 ow.ly/izKf50X2PBz @MoffittNews

Opioid agonist treatment (OAT) can improve HIV outcomes for people with opioid use disorder. In @AIDS_Journal, @CzarinaBehrends and @BruceSchackman explain the urgent need to evaluate the true cost of providing OAT around the world: bit.ly/46gvFVf

Christopher deFilippi and colleagues describe the risks of sudden cardiac death among PWH followed in a substudy of the REPRIEVE trial, now published in AIDS. Check it out here ⬇️ 🔗👉 ow.ly/yKPL50WQZWK #AIDS #suddencardiacdeath